0000899243-21-036426.txt : 20210917
0000899243-21-036426.hdr.sgml : 20210917
20210917164339
ACCESSION NUMBER: 0000899243-21-036426
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210917
FILED AS OF DATE: 20210917
DATE AS OF CHANGE: 20210917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harris Todd
CENTRAL INDEX KEY: 0001711463
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40800
FILM NUMBER: 211260977
MAIL ADDRESS:
STREET 1: 30699 RUSSELL RANCH ROAD
STREET 2: SUITE 140
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tyra Biosciences, Inc.
CENTRAL INDEX KEY: 0001863127
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831476348
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (619) 728-4760
MAIL ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-17
0
0001863127
Tyra Biosciences, Inc.
TYRA
0001711463
Harris Todd
C/O TYRA BIOSCIENCES, INC.
2656 STATE STREET
CARLSBAD
CA
92008
1
1
0
0
Chief Executive Officer
Common Stock
2021-09-17
4
C
0
34007
A
1696343
D
Series A Preferred Stock
2021-09-17
4
C
0
13093
0.00
D
Common Stock
34007
0
D
On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
/s/ John Healy, Attorney-in Fact
2021-09-17